Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Vertex Pharmaceuticals (United Kingdom), United Kingdom, covering academic research published from 2001 to 2023. Read More.
Open Access Percentage
57%
Total
Publications
212
Total Open
Publications
121
Total
Citations
8.8K
Open Access
Percentage
57%
Total
Publications
212
Total Open
Publications
121
Total
Citations
8.8K
Breakdown
Publisher Open
15%
Both
31%
Other Platform Open
11%
Closed
43%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 31%
30
Hybrid 45%
44
No Guarantees 24%
24
Other Platform Open
Domain 78%
69
Institution 53%
47
Preprint 9%
8
Public 7%
6
Other Internet 5%
4
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 69 |
Europe PMC | Domain | 41 |
DOI | Other Internet | 15 |
University of Oxford - Oxford University Research Archive (ORA) | Institution | 14 |
University College London - UCL Discovery | Institution | 6 |
Semantic Scholar | Public | 6 |
bioRxiv | Preprint | 6 |
University of Bristol - Bristol Research | Institution | 5 |
University of Nottingham - Repository@Nottingham | Institution | 4 |
Newcastle Univesity - Newcastle University ePrints | Institution | 4 |